Lonza Group AG - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
LZAGY Over the counter 2830 www.lonza.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Lonza Group AG

A Fresh Look At Indeed Job Postings - Jun 18th, 2025 2:54 pm
The Zacks Analyst Blog Highlights Compagnie de Saint-Gobain, Natwest and Lonza - Jun 10th, 2025 3:00 am
Lonza Group (LZAGY) Upgraded to Strong Buy: Here's Why - May 28th, 2025 10:00 am
Lonza Group Ag (LZAGY) is a Great Momentum Stock: Should You Buy? - May 6th, 2025 10:00 am
Are Medical Stocks Lagging Bayer (BAYRY) This Year? - Apr 9th, 2025 7:40 am
Lonza Group (LZAGY) Upgraded to Buy: Here's What You Should Know - Apr 8th, 2025 10:00 am
Ethris and Lonza to develop mRNA vaccines for respiratory conditions - Apr 8th, 2025 4:17 am
Health Care Roundup: Market Talk - Apr 2nd, 2025 2:58 pm
Lonza Group Ltd (LZAGF) (FY 2024) Earnings Call Highlights: Steady Revenue and Strategic Growth ... - Jan 31st, 2025 12:15 am
JPM 2025: Lonza shares outlook on CHI exit and acquisition strategy - Jan 17th, 2025 1:03 pm
Synaffix secures ADC deals with Boehringer and Mitsubishi Tanabe - Jan 10th, 2025 1:00 am
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix's ADC technology - Jan 9th, 2025 6:00 am
Synaffix and Mitsubishi Tanabe Pharma Sign License Agreement for ADC Technology - Jan 9th, 2025 6:00 am
NVST or LZAGY: Which Is the Better Value Stock Right Now? - Jan 1st, 2025 9:40 am
New Strong Sell Stocks for December 23rd - Dec 22nd, 2024 11:08 pm
Padlock investors sue Bristol Myers; Dietmar Berger is Gilead’s new CMO - Dec 13th, 2024 4:46 am
Elevation Oncology Licenses ADC Technology from Synaffix to Drive Pipeline Expansion - Dec 12th, 2024 5:30 am
Elevation Oncology Expands Pipeline with Nomination of EO-1022, a HER3 ADC for the Treatment of HER3-expressing Solid Tumors - Dec 12th, 2024 5:30 am
Lonza's Synaffix Collaborates with BigHat Biosciences on the Development of a Machine Learning-Designed ADC - Nov 4th, 2024 6:00 am
Lonza Group AG (LZAGY): Among UBS’ Top Tech Based Disruptive Stocks For 2030 - Oct 30th, 2024 7:29 am